0001415889-18-000694.txt : 20180508
0001415889-18-000694.hdr.sgml : 20180508
20180508162248
ACCESSION NUMBER: 0001415889-18-000694
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180204
FILED AS OF DATE: 20180508
DATE AS OF CHANGE: 20180508
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FORTUNOFF GREGORY
CENTRAL INDEX KEY: 0001212542
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-00935
FILM NUMBER: 18814942
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Medite Cancer Diagnostics, Inc.
CENTRAL INDEX KEY: 0000075439
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 364296006
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 414 NORTH ORLEANS STREET
STREET 2: SUITE 502
CITY: CHICAGO
STATE: IL
ZIP: 60610
BUSINESS PHONE: 4078490290
MAIL ADDRESS:
STREET 1: 414 NORTH ORLEANS STREET
STREET 2: SUITE 502
CITY: CHICAGO
STATE: IL
ZIP: 60610
FORMER COMPANY:
FORMER CONFORMED NAME: CytoCore Inc
DATE OF NAME CHANGE: 20060815
FORMER COMPANY:
FORMER CONFORMED NAME: MOLECULAR DIAGNOSTICS INC
DATE OF NAME CHANGE: 20011009
FORMER COMPANY:
FORMER CONFORMED NAME: AMPERSAND MEDICAL CORP
DATE OF NAME CHANGE: 19990527
4
1
form4-05082018_010535.xml
X0306
4
2018-02-04
0000075439
Medite Cancer Diagnostics, Inc.
MDIT
0001212542
FORTUNOFF GREGORY
C/O MEDITE CANCER DIAGNOSTICS, INC.
4203 SW 34TH ST.
ORLANDO
FL
32811
true
false
false
false
Common Stock
2018-04-04
4
P
0
1333334
0.75
A
1533334
D
Secured Convertible Note
.075
2018-02-04
4
P
0
100000
.075
A
2018-08-04
2020-02-04
Common Stock
1333334
100000
D
/s/ Greg Fortunoff
2018-05-08